Tumor type | Expression | Significant clinical features | Prognosis | Diagnosis | Ref. | ||
---|---|---|---|---|---|---|---|
Tumor vs. normal tissues | Fold change | Sample size | |||||
Pituitary adenoma | Upregulated | ~ 6.5-fold | 38 pairs of adenoma and adjacent normal tissues (qRT-PCR) | – | – | – | [34] |
Oral squamous cell carcinoma | Upregulated | ~ 4-fold | 50 pairs of adenoma and adjacent normal tissues (qRT-PCR) | – | – | – | [35] |
Nasopharyngeal carcinoma | Upregulated | ~ 2.5-fold | 45 pairs of adenoma and adjacent normal tissues (qRT-PCR) | – | – | – | [37] |
Nasopharyngeal carcinoma | Upregulated | ~ 6-fold | 45 paired of adenoma and adjacent normal tissues (qRT-PCR) | – | – | – | [36] |
Non-small cell lung cancer | Upregulated | ~ 1.5-fold | 135 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Lymph node metastasis, TNM stage | OS | – | [40] |
Non-small cell lung cancer | Upregulated | ~ 2-fold | 76 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Tumor size, lymph node metastasis, TNM stage | OS | – | [39] |
– | 526 cancer and 59 normal samples in LUAD, and 501 cancer and 49 normal samples in LUSC (starBase v3.0 database) | ||||||
– | 486 cancer and 338 normal samples in LUSC (GEPIA database) | ||||||
– | GEO datasets (GSE18842 and GSE19188) | ||||||
Lung squamous cell carcinoma | Upregulated | – | 3 pairs of LUSC tissues and normal lung tissues (qRT-PCR) | Ethnicity | – | AUC of 0.983 (95% CI 0.973–0.993, P < 0.0001) | [38] |
– | 502 cancer and 49 normal samples in LUSC (TCGA dataset) | ||||||
– | GEO datasets (GSE19188, GSE30219, GSE103512, E‑MTAB‑5231) | ||||||
Esophageal carcinoma | Upregulated | ~ 12-fold | 45 pairs of adenoma and adjacent normal tissues (qRT-PCR) | – | – | – | [45] |
Esophageal squamous cell carcinoma | Upregulated | ~ 2-fold | 78 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Tumor size, lymph node metastasis, TNM stage | OS | [44] | |
– | 182 adenoma and 286 normal tissues (GEPIA database) | ||||||
Esophageal squamous cell carcinoma | Upregulated | ~ 2.75-fold | 45 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Tumor size | OS | AUC of 0.7668 (95% CI 0.6399 to 0.8937, P < 0.001) | [43] |
– | 182 adenoma and 13 normal tissues (GEPIA database) | ||||||
Esophageal squamous cell carcinoma | Upregulated | – | 182 adenoma and 286 normal tissues (GEPIA database) | – | – | – | [42] |
– | 162 cancer and 11 normal samples (starBase v3.0 database) | ||||||
Esophageal carcinoma | Upregulated | ~ 3.75-fold | 45 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Lymph node metastasis, TNM stage | OS | – | [41] |
Gastric cancer | Upregulated | ~ 3-fold | 40 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Lymph node metastasis | – | – | [48] |
– | 408 tumor samples and 211 normal samples (GEPIA database) | ||||||
Hepatocellular carcinoma | Upregulated | ~ 2-fold | 83 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Vascular invasion, TNM stage | OS | – | [46] |
Hepatocellular carcinoma | Upregulated | ~ 2-fold | 374 tumor samples and 50 normal samples (GENCODE database) | Vascular invasion, tumor grade, tumor stage | OS, DFS | [47] | |
Ovarian cancer | Upregulated | – | 426 tumor samples and 88 normal samples (TCGA database) | – | – | – | [51] |
Cervical cancer | Upregulated | ~ 2-fold | 100 pairs of adenoma and adjacent normal tissues (qRT-PCR) | Tumor size, differentiation, distant metastasis, FIGO stage | OS | – | [53] |
– | 306 tumor samples and 13 normal samples (GEPIA database) | ||||||
Cervical cancer | Upregulated | – | 306 tumor samples and 13 normal samples (GEPIA database) | – | – | – | [52] |